Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Induction of remission in Wegener's granulomatosis with low dose methotrexate.

de Groot K, Mühler M, Reinhold-Keller E, Paulsen J, Gross WL.

J Rheumatol. 1998 Mar;25(3):492-5.

PMID:
9517769
2.
3.

Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole.

de Groot K, Reinhold-Keller E, Tatsis E, Paulsen J, Heller M, Nölle B, Gross WL.

Arthritis Rheum. 1996 Dec;39(12):2052-61.

PMID:
8961911
4.

High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate.

Reinhold-Keller E, Fink CO, Herlyn K, Gross WL, De Groot K.

Arthritis Rheum. 2002 Jun 15;47(3):326-32.

5.

An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone.

Sneller MC, Hoffman GS, Talar-Williams C, Kerr GS, Hallahan CW, Fauci AS.

Arthritis Rheum. 1995 May;38(5):608-13.

PMID:
7748215
6.

Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience.

Villa-Forte A, Clark TM, Gomes M, Carey J, Mascha E, Karafa MT, Roberson G, Langford CA, Hoffman GS.

Medicine (Baltimore). 2007 Sep;86(5):269-77.

7.

Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease.

Reinhold-Keller E, De Groot K, Rudert H, Nölle B, Heller M, Gross WL.

QJM. 1996 Jan;89(1):15-23.

PMID:
8730339
8.

Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.

Metzler C, Miehle N, Manger K, Iking-Konert C, de Groot K, Hellmich B, Gross WL, Reinhold-Keller E; German Network of Rheumatic Diseases..

Rheumatology (Oxford). 2007 Jul;46(7):1087-91. Epub 2007 May 22.

PMID:
17519271
9.
10.

[Treatment of Wegener's granulomatosis].

Riccieri V, Valesini G.

Reumatismo. 2004 Apr-Jun;56(2):69-76. Review. Italian.

11.

The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate.

Hoffman GS, Leavitt RY, Kerr GS, Fauci AS.

Arthritis Rheum. 1992 Nov;35(11):1322-9.

PMID:
1445449
12.

A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.

Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, Lesavre P, Jacquot C, Bindi P, Bielefeld P, Desson JF, Détrée F, Dubois A, Hachulla E, Hoen B, Jacomy D, Seigneuric C, Lauque D, Stern M, Longy-Boursier M.

Arthritis Rheum. 1997 Dec;40(12):2187-98.

PMID:
9416856
13.
14.

Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.

Pagnoux C, Mahr A, Hamidou MA, Boffa JJ, Ruivard M, Ducroix JP, Kyndt X, Lifermann F, Papo T, Lambert M, Le Noach J, Khellaf M, Merrien D, Puéchal X, Vinzio S, Cohen P, Mouthon L, Cordier JF, Guillevin L; French Vasculitis Study Group..

N Engl J Med. 2008 Dec 25;359(26):2790-803. doi: 10.1056/NEJMoa0802311.

15.

Maintenance of remission with leflunomide in Wegener's granulomatosis.

Metzler C, Fink C, Lamprecht P, Gross WL, Reinhold-Keller E.

Rheumatology (Oxford). 2004 Mar;43(3):315-20. Epub 2004 Jan 6.

PMID:
14963200
16.
17.

Etanercept plus standard therapy for Wegener's granulomatosis.

Wegener's Granulomatosis Etanercept Trial (WGET) Research Group..

N Engl J Med. 2005 Jan 27;352(4):351-61.

18.

Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.

Martinez V, Cohen P, Pagnoux C, Vinzio S, Mahr A, Mouthon L, Sailler L, Delaunay C, Sadoun A, Guillevin L; French Vasculitis Study Group..

Arthritis Rheum. 2008 Jan;58(1):308-17. doi: 10.1002/art.23147.

19.

Wegener's granulomatosis: a challenging disease for otorhinolaryngologists.

Cadoni G, Prelajade D, Campobasso E, Calŏ L, Agostino S, Manna R, Paludetti G.

Acta Otolaryngol. 2005 Oct;125(10):1105-10.

PMID:
16298794

Supplemental Content

Support Center